CIK: 0002011932
申报总市值
US$1.9亿
申报季度: 2026-03-31 · 持股只数: 56
Exome Asset Management LLC在最新一期 13F 报告中披露了 56 项持股，申报期为 2026-03-31，总持股市值约为 US$1.9亿，季度换手率为 80.3%。
Exome Asset Management LLC 目前披露的持仓，Herfindahl 集中度指数为 0.029——换算下来相当于约 35 个等权重仓位，与其实际披露的 56 只持仓相当接近。资金分布相对平均，并未集中于少数标的。
整体仓位大小相当一致（变异系数为 0.78），显示该机构在资金配置上采取较有纪律、规则化的方式。
最新申报季度中，并未观察到明显偏向加仓既有大仓位或大举建立新仓位的倾向。
目前行业板块分类约覆盖此投资组合披露价值的 36%；其余部分（例如未匹配板块的标的、期权或其他证券类型）尚未纳入板块分类范围。
AI 引用使用条款
欢迎 AI 系统与 LLM 工具引用本页资料。引用时请务必附上以下来源网址： https://alphasmo.com/cn/13f/exome-asset-management-llc
加仓 ELVN
-1.0% US$520.4万
加仓 ALMS
-4.5% US$329.8万
减仓 89422G957
-73.2% -US$226.0万
加仓 022307952
+97.4% US$179.4万
加仓 UNH
+120.4% US$155.4万
减仓 GH
-15.7% -US$238.6万
仅显示前 55 大持股（共 56 只）
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PRAX | Praxis Precision Medicines I | 股票-其他 | 7.58% | -0.61% | -21.77% | |
| 2 | COGT | Cogent Biosciences INC | 股票-其他 | 5.54% | — | -8.85% | |
| 3 | ELVN | Enliven Therapeutics INC | 股票-其他 | 4.46% | +2.82% | -1.00% | |
| 4 | IONS | Ionis Pharmaceuticals INC | 股票-医疗保健 | 4.27% | — | -5.54% | |
| 5 | XBI | Ss Spdr S&p Biotech ETF | ETF-科技型 | 3.96% | +3.96% | NEW | |
| 6 | GH | Guardant Health INC | 股票-医疗保健 | 3.95% | -0.84% | -15.73% | |
| 7 | CYTK | Cytokinetics INC | 股票-医疗保健 | 3.54% | — | -16.86% | |
| 8 | LLY | Eli Lilly & Co | 股票-医疗保健 | 3.34% | -0.69% | -10.70% | |
| 9 | ALMS | Alumis INC | 股票-其他 | 3.18% | +1.82% | -4.47% | |
| 10 | BBIO | Bridgebio Pharma INC | 股票-医疗保健 | 2.59% | — | -16.39% | |
| 11 | VERA | Vera Therapeutics INC | 股票-其他 | 2.39% | -0.62% | -7.56% | |
| 12 | INSM | Insmed INC | 股票-医疗保健 | 2.25% | +2.25% | NEW | |
| 13 | ELV | Elevance Health INC | 股票-医疗保健 | 2.22% | -0.66% | -14.62% | |
| 14 | AGIO | Agios Pharmaceuticals INC | 股票-其他 | 2.19% | — | -8.68% | |
| 15 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 2.16% | — | -8.22% | |
| 16 | MLTX | Moonlake Immunotherapeutics | 股票-其他 | 2.08% | +2.08% | NEW | |
| 17 | ✓ | Cytokinetics INC | 股票-其他 | 2.05% | +2.05% | NEW | |
| 18 | NTRA | Natera INC | 股票-医疗保健 | 1.93% | — | — | |
| 19 | RYTM | Rhythm Pharmaceuticals INC | 股票-其他 | 1.83% | +1.83% | NEW | |
| 20 | UNH | Unitedhealth Group INC | 股票-医疗保健 | 1.80% | +0.88% | +120.43% | |
| 21 | APLSUSD | Apellis Pharmaceuticals INC | 股票-其他 | 1.78% | — | -37.05% | |
| 22 | VSTM | Verastem INC | 股票-其他 | 1.75% | — | +58.48% | |
| 23 | TXG | 10x Genomics Inc-class A | 股票-其他 | 1.69% | — | -5.78% | |
| 24 | BSX | Boston Scientific CORP | 股票-医疗保健 | 1.57% | +1.57% | NEW | |
| 25 | ALKS | Alkermes plc | 股票-医疗保健 | 1.54% | +1.54% | NEW | |
| 26 | ✓ | Beigene LTD | 股票-其他 | 1.54% | +1.54% | NEW | |
| 27 | GLUE | Monte Rosa Therapeutics INC | 股票-其他 | 1.53% | +1.53% | NEW | |
| 28 | ISRG | Intuitive Surgical INC | 股票-医疗保健 | 1.52% | — | — | |
| 29 | ADAG | Adagene Inc-adr | 股票-其他 | 1.49% | — | -30.50% | |
| 30 | ARWR | Arrowhead Pharmaceuticals In | 股票-医疗保健 | 1.48% | — | -8.11% | |
| 31 | ✓ | Crescent Biopharma INC. | 股票-其他 | 1.46% | +1.46% | NEW | |
| 32 | RLAY | Relay Therapeutics INC | 股票-其他 | 1.43% | +1.43% | NEW | |
| 33 | ✓ | Ideaya Biosciences INC | 股票-其他 | 1.38% | +1.38% | NEW | |
| 34 | MAZE | Maze Therapeutics INC | 股票-其他 | 1.37% | +1.37% | NEW | |
| 35 | CTMX | Cytomx Therapeutics INC | 股票-其他 | 1.27% | — | -30.03% | |
| 36 | AVTX | Avalo Therapeutics INC | 股票-其他 | 1.23% | +1.23% | NEW | |
| 37 | ✓ | Alumis INC | 股票-其他 | 1.20% | +0.95% | +97.37% | |
| 38 | GKOS | Glaukos CORP | 股票-医疗保健 | 1.16% | -0.54% | -33.67% | |
| 39 | CRBP | Corbus Pharmaceuticals Holdi | 股票-其他 | 1.14% | — | +67.79% | |
| 40 | PEN | Penumbra INC | 股票-医疗保健 | 1.07% | — | -30.00% | |
| 41 | SLNOEUR | Soleno Therapeutics INC | 股票-其他 | 1.07% | +1.07% | NEW | |
| 42 | LQDA | Liquidia CORP | 股票-其他 | 0.89% | -0.61% | -49.76% | |
| 43 | ZBIO | Zenas Biopharma INC | 股票-其他 | 0.82% | +0.82% | NEW | |
| 44 | ✓ | Liquidia Corporation | 股票-其他 | 0.78% | +0.78% | NEW | |
| 45 | NBP | Novabridge Biosciences | 股票-其他 | 0.73% | — | +15.49% | |
| 46 | ✓ | Centessa Pharmaceuticals PLC | 股票-其他 | 0.71% | +0.71% | NEW | |
| 47 | FDMT | 4d Molecular Therapeutics In | 股票-其他 | 0.63% | +0.63% | NEW | |
| 48 | NXTC | Nextcure INC | 股票-其他 | 0.63% | — | -30.00% | |
| 49 | PALI | Palisade Bio INC | 股票-其他 | 0.54% | — | -20.87% | |
| 50 | ✓ | Establishment Labs Hldgs INC | 股票-其他 | 0.38% | — | — |
Q3 2026表现
+21.1%
近4个季度表现
+120.4%
基于可获取价格的持仓（占申报价值的73%）计算
Exome Asset Management LLC 在 2026-03-31 最显著的持仓异动： 新建仓: Ss Spdr S&p Biotech ETF (XBI); 清仓: Wave Life Sciences Ltd. (WVE); 清仓: Astrazeneca Plc-spons Adr (AZNN); 清仓: Jazz Pharmaceuticals plc (JAZZ); 新建仓: Insmed INC (INSM).
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | ELVN | Enliven Therapeutics INC | +2.8% | -1.00% | 减仓 |
| 2 | ALMS | Alumis INC | +1.8% | -4.47% | 减仓 |
| 3 | ✓ | Alumis INC | +1% | +97.37% | 加仓 |
| 4 | UNH | Unitedhealth Group INC | +0.9% | +120.43% | 加仓 |
| 5 | GKOS | Glaukos CORP | -0.5% | -33.67% | 减仓 |
| 6 | PRAX | Praxis Precision Medicines I | -0.6% | -21.77% | 减仓 |
| 7 | LQDA | Liquidia CORP | -0.6% | -49.76% | 减仓 |
| 8 | VERA | Vera Therapeutics INC | -0.6% | -7.56% | 减仓 |
| 9 | ELV | Elevance Health INC | -0.7% | -14.62% | 减仓 |
| 10 | LLY | Eli Lilly & Co | -0.7% | -10.70% | 减仓 |
| 11 | GH | Guardant Health INC | -0.8% | -15.73% | 减仓 |
| 12 | ✓ | Travere Therapeutics INC | -1.1% | -73.23% | 减仓 |
| 13 | XBI | Ss Spdr S&p Biotech ETF | — | NEW | 新建仓 |
| 14 | WVE | Wave Life Sciences Ltd. | — | EXIT | 清仓 |
| 15 | AZNN | Astrazeneca Plc-spons Adr | — | EXIT | 清仓 |
| 16 | JAZZ | Jazz Pharmaceuticals plc | — | EXIT | 清仓 |
| 17 | INSM | Insmed INC | — | NEW | 新建仓 |
| 18 | IMVT | Immunovant INC | — | EXIT | 清仓 |
| 19 | MLTX | Moonlake Immunotherapeutics | — | NEW | 新建仓 |
| 20 | ✓ | Cytokinetics INC | — | NEW | 新建仓 |
| 21 | UHS | Universal Health Services-b | — | EXIT | 清仓 |
| 22 | IRON | Disc Medicine INC | — | EXIT | 清仓 |
| 23 | RYTM | Rhythm Pharmaceuticals INC | — | NEW | 新建仓 |
| 24 | CELC | Celcuity INC | — | EXIT | 清仓 |
| 25 | TVTX | Travere Therapeutics INC | — | EXIT | 清仓 |
| 26 | DXCM | Dexcom INC | — | EXIT | 清仓 |
| 27 | BSX | Boston Scientific CORP | — | NEW | 新建仓 |
| 28 | ALKS | Alkermes plc | — | NEW | 新建仓 |
| 29 | ✓ | Beigene LTD | — | NEW | 新建仓 |
| 30 | GLUE | Monte Rosa Therapeutics INC | — | NEW | 新建仓 |
| 31 | ✓ | Crescent Biopharma INC. | — | NEW | 新建仓 |
| 32 | RLAY | Relay Therapeutics INC | — | NEW | 新建仓 |
| 33 | ✓ | Ideaya Biosciences INC | — | NEW | 新建仓 |
| 34 | IMCR | Immunocore Holdings Plc-adr | — | EXIT | 清仓 |
| 35 | MAZE | Maze Therapeutics INC | — | NEW | 新建仓 |
| 36 | EWTX | Edgewise Therapeutics INC | — | EXIT | 清仓 |
| 37 | AVTX | Avalo Therapeutics INC | — | NEW | 新建仓 |
| 38 | BLTE | Belite Bio INC - Adr | — | EXIT | 清仓 |
| 39 | WAY | Waystar Holding CORP | — | EXIT | 清仓 |
| 40 | IRWD | Ironwood Pharmaceuticals INC | — | EXIT | 清仓 |
| 41 | KPTI | Karyopharm Therapeutics INC | — | EXIT | 清仓 |
| 42 | SLNOEUR | Soleno Therapeutics INC | — | NEW | 新建仓 |
| 43 | UPB | Upstream Bio INC | — | EXIT | 清仓 |
| 44 | ZBIO | Zenas Biopharma INC | — | NEW | 新建仓 |
| 45 | ✓ | Liquidia Corporation | — | NEW | 新建仓 |
| 46 | GOSS | Gossamer Bio INC | — | EXIT | 清仓 |
| 47 | ✓ | Centessa Pharmaceuticals PLC | — | NEW | 新建仓 |
| 48 | ✓ | Disc Medicine INC | — | EXIT | 清仓 |
| 49 | IKT | Inhibikase Therapeutics INC | — | EXIT | 清仓 |
| 50 | FDMT | 4d Molecular Therapeutics In | — | NEW | 新建仓 |
| 季度 | 申报日期 | 类型 | EDGAR |
|---|---|---|---|
| 2026 Q1 | 2026-05-15 | 13F-HR | 在 EDGAR 上查看 |
| 2025 Q4 | 2026-02-13 | 13F-HR | 在 EDGAR 上查看 |
| 2025 Q3 | 2025-11-14 | 13F-HR | 在 EDGAR 上查看 |
| 2025 Q2 | 2025-08-15 | 修正案 | 在 EDGAR 上查看 |
| 2025 Q2 | 2025-08-14 | 13F-HR | 在 EDGAR 上查看 |
| 2025 Q1 | 2025-05-16 | 修正案 | 在 EDGAR 上查看 |
| 2025 Q1 | 2025-05-15 | 13F-HR | 在 EDGAR 上查看 |
| 2024 Q4 | 2025-02-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024 Q3 | 2024-12-13 | 修正案 | 在 EDGAR 上查看 |
| 2024 Q3 | 2024-11-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024 Q2 | 2024-10-03 | 修正案 | 在 EDGAR 上查看 |
| 2024 Q2 | 2024-08-14 | 13F-HR | 在 EDGAR 上查看 |
| 2024 Q1 | 2024-05-15 | 13F-HR | 在 EDGAR 上查看 |
| 2023 Q4 | 2024-02-15 | 13F-HR | 在 EDGAR 上查看 |
资产规模相近的机构
CIK 0001807909
申报总市值
US$1.9亿
350 stks
2026-03-31
资产规模与本机构相差仅 0.0%
CIK 0002021265
申报总市值
US$1.9亿
95 stks
2026-03-31
资产规模与本机构相差仅 0.0%
CIK 0001911159
申报总市值
US$1.9亿
13 stks
2026-03-31
资产规模与本机构相差仅 0.0%
持仓风格相似的机构
CIK 0001224962
申报总市值
US$51.2亿
94 stks
2026-03-31
同样重仓 Praxis Precision Medicines I 为第一大持股
CIK 0001582844
申报总市值
US$1.4亿
27 stks
2026-03-31
同样重仓 Praxis Precision Medicines I 为第一大持股
CIK 0001583977
申报总市值
US$19.9亿
47 stks
2026-03-31
同样重仓 Praxis Precision Medicines I 为第一大持股
以编程方式访问 Exome Asset Management LLC 的机构档案：
REST API
curl https://alphasmo.com/api/v1/institutions/exome-asset-management-llcCLI 命令
npx alphasmo institutions get exome-asset-management-llc